<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Batth TS</submitter><funding>European Molecular Biology Organization</funding><funding>Horizon 2020 Framework Programme</funding><funding>Kræftens Bekæmpelse</funding><funding>Novo Nordisk Foundation Center for Protein Research</funding><funding>Lundbeckfonden</funding><funding>Novo Nordisk Fonden</funding><funding>Wellcome Trust</funding><funding>Lundbeck Foundation</funding><pagination>2784-2796</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7618100</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(10)</volume><pubmed_abstract>Despite its low cellular abundance, phosphotyrosine (pTyr) regulates numerous cell signaling pathways in health and disease. We applied comprehensive phosphoproteomics to unravel differential regulators of receptor tyrosine kinase (RTK)-initiated signaling networks upon activation by Pdgf-ββ, Fgf-2, or Igf-1 and identified more than 40,000 phosphorylation sites, including many phosphotyrosine sites without additional enrichment. The analysis revealed RTK-specific regulation of hundreds of pTyr sites on key signaling molecules. We found the tyrosine phosphatase Shp-2 to be the master regulator of Pdgfr pTyr signaling. Application of a recently introduced allosteric Shp-2 inhibitor revealed global regulation of the Pdgf-dependent tyrosine phosphoproteome, which significantly impaired cell migration. In addition, we present a list of hundreds of Shp-2-dependent targets and putative substrates, including Rasa1 and Cortactin with increased pTyr and Gab1 and Erk1/2 with decreased pTyr. Our study demonstrates that large-scale quantitative phosphoproteomics can precisely dissect tightly regulated kinase-phosphatase signaling networks.</pubmed_abstract><journal>Cell reports</journal><pubmed_title>Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling.</pubmed_title><pmcid>PMC7618100</pmcid><funding_grant_id>R90-A5844</funding_grant_id><funding_grant_id>NNF14CC0001</funding_grant_id><funding_grant_id>MSmed 686547</funding_grant_id><funding_grant_id>8107636/Z/15/Z</funding_grant_id><funding_grant_id>107636</funding_grant_id><funding_grant_id>R191-2015-703</funding_grant_id><funding_grant_id>PI Jesper Velgaard Olsen</funding_grant_id><pubmed_authors>Papetti M</pubmed_authors><pubmed_authors>Olsen JV</pubmed_authors><pubmed_authors>Francavilla C</pubmed_authors><pubmed_authors>Batth TS</pubmed_authors><pubmed_authors>Tollenaere MAX</pubmed_authors><pubmed_authors>Pfeiffer A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling.</name><description>Despite its low cellular abundance, phosphotyrosine (pTyr) regulates numerous cell signaling pathways in health and disease. We applied comprehensive phosphoproteomics to unravel differential regulators of receptor tyrosine kinase (RTK)-initiated signaling networks upon activation by Pdgf-ββ, Fgf-2, or Igf-1 and identified more than 40,000 phosphorylation sites, including many phosphotyrosine sites without additional enrichment. The analysis revealed RTK-specific regulation of hundreds of pTyr sites on key signaling molecules. We found the tyrosine phosphatase Shp-2 to be the master regulator of Pdgfr pTyr signaling. Application of a recently introduced allosteric Shp-2 inhibitor revealed global regulation of the Pdgf-dependent tyrosine phosphoproteome, which significantly impaired cell migration. In addition, we present a list of hundreds of Shp-2-dependent targets and putative substrates, including Rasa1 and Cortactin with increased pTyr and Gab1 and Erk1/2 with decreased pTyr. Our study demonstrates that large-scale quantitative phosphoproteomics can precisely dissect tightly regulated kinase-phosphatase signaling networks.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2026-04-20T03:20:24.938Z</modification><creation>2026-04-20T03:10:14.743Z</creation></dates><accession>S-EPMC7618100</accession><cross_references><pubmed>29514104</pubmed><doi>10.1016/j.celrep.2018.02.038</doi></cross_references></HashMap>